Leber Laura 4

Accession 0001209191-19-056639

CIK 0001131324other

View on SEC.gov Company Profile

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 9:44 PM ET

Size

34.9 KB

Accession

0001209191-19-056639

Insider Transaction Report

Form 4

Period: 2019-11-08

GENOMIC HEALTH INCGHDX

Leber Laura

Chief Communication Officer

Transactions

Disposition to Issuer
Common Stock
2019-11-08−9,384→ 0 total
Disposition to Issuer
Employee Stock Option (right to buy)
2019-11-08−15,000→ 0 total
Exercise: $29.34Exp: 2022-02-03→ Common Stock (15,000 underlying)
Disposition to Issuer
Employee Stock Option (right to buy)
2019-11-08−10,220→ 0 total
Exercise: $30.84Exp: 2024-01-28→ Common Stock (10,220 underlying)
Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−9,000→ 0 total
Exercise: $31.12Exp: 2025-02-13→ Common Stock (9,000 underlying)
Disposition to Issuer
Common Stock
2019-11-08−4,352→ 9,384 total
Disposition to Issuer
Employee Stock Option (right to buy)
2019-11-08−11,250→ 0 total
Exercise: $28.05Exp: 2023-01-31→ Common Stock (11,250 underlying)
Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−11,458→ 1,042 total
Exercise: $27.00Exp: 2026-02-16→ Common Stock (11,458 underlying)
Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−1,042→ 0 total
Exercise: $27.00Exp: 2026-02-16→ Common Stock (1,042 underlying)
Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−8,366→ 3,804 total
Exercise: $27.48Exp: 2027-01-31→ Common Stock (8,366 underlying)
Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−3,804→ 0 total
Exercise: $27.48Exp: 2027-01-31→ Common Stock (3,804 underlying)
Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−6,190→ 7,960 total
Exercise: $33.21Exp: 2028-01-31→ Common Stock (6,190 underlying)
Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−7,960→ 0 total
Exercise: $33.21Exp: 2028-01-31→ Common Stock (7,960 underlying)
Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−8,100→ 0 total
Exercise: $72.52Exp: 2029-01-29→ Common Stock (8,100 underlying)

Footnotes (13)

[F1]Disposed of in connection with the acquisition of Issuer (the "Merger") by Exact Sciences Corporation ("Exact Sciences") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the "Merger Agreement"), among Exact Sciences,Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $119,704 and 1,960 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
[F10]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 2,911 shares of Exact Sciences common stock with an exercise price of $35.91 per share.
[F11]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $85,642, less applicable tax withholdings, and 1,402 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
[F12]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 6,092 shares of Exact Sciences common stock with an exercise price of $43.40 per share.
[F13]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 6,199 shares of Exact Sciences common stock with an exercise price of $94.76 per share.
[F2]Disposed of in connection with the Merger, whereby such Issuer restricted stock unit ("RSU") was assumed by Exact Sciences and converted into a corresponding award for 7,180 RSUs of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
[F3]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $231,418, less applicable tax withholdings, and 3,790 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
[F4]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $179,535, less applicable tax withholdings, and 2,940 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
[F5]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $151,366, less applicable tax withholdings, and 2,479 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
[F6]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $132,260, less applicable tax withholdings, and 2,166 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
[F7]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $187,805, less applicable tax withholdings, and 3,076 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
[F8]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 797 shares of Exact Sciences common stock with an exercise price of $35.28 per share.
[F9]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $135,473, less applicable tax withholdings, and 2,218 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

GENOMIC HEALTH INC

CIK 0001131324

→

Entity typeother

Related Parties

filerCIK 0001649191

Filing Metadata

Form type: 4
Filed: Nov 13, 7:00 PM ET
Accepted: Nov 14, 9:44 PM ET
Size: 34.9 KB

View on SEC.gov